Outset Medical Inc. (OM) to Offer 4M Shares of Common Stock

Outset Medical, Inc. (Nasdaq: OM) announced today the commencement of a proposed underwritten public offering of 4,000,000 shares of its common stock by certain of its stockholders. In addition, such selling stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock in the offering. Outset is not selling any shares and will not receive any of the proceeds from the sale of the shares of common stock being offered by the selling stockholders. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

BofA Securities, Morgan Stanley and Goldman Sachs & Co. LLC are acting as joint lead book-running managers for the offering. SVB Leerink and Stifel are acting as co-managers for the offering.

You May Also Be Interested In

• MapLight Therapeutics raises $150M in private placement
• Outlook Therapeutics prices $55M public offering of stock and warrants
• Curis prices $5.6M public offering at $1.50 per share